Original Article

Dexmedetomidine Versus Ketamine Combined With Fentanyl for Sedation-Analgesia in Colonoscopy Procedures: A Randomized Prospective Study

Abstract

Colonoscopy is a painful, embarrassing and short-term procedure that needs temporary sedation and rapid recovery. The aim of this study was to compare the sedation and analgesia effect and hemodynamic changes due to bolus intravenous injection of dexmedetomidine and ketamine during elective colonoscopy. This clinical trial was conducted on 70 patients aged 20-70 years, candidates for elective colonoscopy, who randomly divided into two equal groups. For all patients 0.03 mg/kg midazolam 10 min before procedure was injected. Fentanyl 1 µ/kg was administrated in both groups 5 min before procedure, and one min before colonoscopy. K group received 0.5 mg/kg ketamine and D group received 1 µ/kg dexmedetomidine. Then, the normal saline infusion was used as maintenance. Fentanyl 25-50 µg was prescribed as the rescue dose if needed during the procedure. Hemodynamic changes, sedation level during procedure, patients and colonoscopists satisfaction were recorded in recovery. The mean heart rate and mean blood pressure was significantly less in the dexmedetomidine group than in the ketamine group. All of the patients in the ketamine group were deep to moderately sedated during colonoscopy, and the amount of fentanyl required in this group is much less than dexmedetomidine group (68.02±25.63 vs 91.45±38.62 µg P-0.003). In terms of satisfaction, only 42% of patients in the dexmedetomidine group were completely satisfied with colonoscopy, while 65% of Ketamine group had complete satisfaction with colonoscopy (P=0.001). The level of colonoscopist satisfaction during colonoscopy was similar in both group, and complete satisfaction was 43%. In patients undergoing colonoscopy, IV bolus injection of dexmedetomidine in comparison with ketamine provides less patients satisfactory and low level of sedation with supplemental multiple doses of fentanyl during the procedure.

 

 

 

 

1. Padmanabhan U, Leslie K, Eer ASY, Maruff P, Silbert BS. Early cognitive impairment after sedation for colonoscopy: the effect of adding midazolam and/or fentanyl to propofol. Anesth Analg. 2009;109:1448-55.
2. Cohen J, Saltzman JR, Travis AC. Overview of procedural sedation for gastrointestinal endoscopy. 2013.
3. Sula H, Domi R, Ohri I, Broqi I, Beqiri A, Gani H. Propofol dexmedetomidine for sedation in colonoscopy: A prospective, domized study: 2AP1-7. Eur J Anaesthesiol. 2012;29:32.
4. Rex DK, Petrini JL, Baron TH, Chak A, Cohen J, Deal SE, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2006;63:16-28.
5. Lichtenstein DR, Jagannath S, Baron TH, Anderson MA, Banerjee S; Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy, et al. Sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2008;68:815–26.
6. Thomas MC, Jennett-Reznek AM, Patanwala AE. Combination of ketamine and propofol versus either agent alone for procedural sedation in the emergency department. Am J Health Syst Pharm 2011;68:2248-56.
7. Weerink MA, Struys MM, Hannivoort LN, Barends CR, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet 2017;56:893-913.
8. Shukry M, Miller JA. Update on dexmedetomidine: use in nonintubated patients requiring sedation for surgical procedures. Ther Clin Risk Manag 2010;6:111-21.
9. Jalowiecki P, Rudner R, Gonciarz M, Kawecki P, Petelenz M, Dziurdzik P. Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy. Anesthesiology: Anesthesiology 2005;103:269-73.
10. Pasin L, Greco T, Feltracco P, Vittorio A, Neto CN, Cabrini L, et al. Dexmedetomidine as a sedative agent in critically ill patients: a meta-analysis of randomized controlled trials. PLoS One 2013;8:e82913.
11. Paris A, Tonner PH. Dexmedetomidine in anaesthesia. Curr Opin Anaesthesiol 2005;18:412-8.
12. Giovannitti Jr JA, Thoms SM, Crawford JJ. Alpha-2 adrenergic receptor agonists: a review of current clinical applications. Anesth Prog 2015;62:31-8.
13. Wu W, Chen Q, Zhang LC, Chen WH. Dexmedetomidine versus midazolam for sedation in upper gastrointestinal endoscopy. J Int Med Res 2014;42:516-22.
14. Amri P, Nahrini S, Hajian-Tilaki K, Hamidian M, Alipour SF, Hamidi SH, et al. Analgesic Effect and Hemodynamic Changes Due to Dexmedetomidine Versus Fentanyl During Elective Colonoscopy: A Double-Blind Randomized Clinical Trial. Anesthesiology and pain medicine. 2018;8:6.
15. Precedex(Dexmedetomidine hydrochloride) Drug Information: Clinical Pharmacology - Prescribing Information at RxList". RxList. Retrieved 2015-11-16.
16. Klamt JG, Vicente WV, Garcia LV, Ferreira CA. Effects of dexmedetomidine-fentanyl infusion on blood pressure and heart rate during cardiac surgery in children. Anesthesiol Res Pract 2010;2010: 869049.
17. Khajavi M, Emami A, Etezadi F, Safari S, Sharifi A, Moharari RS. Conscious sedation and analgesia in colonoscopy: Ketamine/propofol combination has superior patient satisfaction versus fentanyl/propofol. Anesth Pain Med 2013;3:208-213.
18. Tuncali B, Pekcan YO, Celebi A, Zeyneloglu P. Addition of low-dose ketamine to midazolam-fentanyl-propofol–based sedation for colonoscopy: a randomized, double-blind, controlled trial. J Clin Anesth 2015;27:301-6.
19. Türk HŞ, Aydoğmuş M, Ünsal O, Işıl CT, Citgez B, Oba S, et al. Ketamine versus alfentanil combined with propofol for sedation in colonoscopy procedures: a randomized prospective study. Turk J Gastroenterol 2014;25:644-9.
Files
IssueVol 57, No 6 (2019) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/acta.v57i6.1878
Keywords
Sedation Colonoscopy Dexmedetomidine Ketamine Satisfaction

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Pourfakhr P, Nouri K, Shariefnia HR, Moharari RS, Khajavi MR. Dexmedetomidine Versus Ketamine Combined With Fentanyl for Sedation-Analgesia in Colonoscopy Procedures: A Randomized Prospective Study. Acta Med Iran. 2019;57(6):355-358.